1. Home
  2. JAGX

JAGX

Jaguar Health Inc.

Logo Jaguar Health Inc.

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-24-2024 4:00pm EST

$
-
.
-
-
+$
-
.
-
-
+
-
.
-
-
%

Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its product Mytesi is a novel, first-in-class anti-secretory agent which has a basic normalizing effect locally on the gut, and this mechanism of action has the potential to benefit multiple disorders. It has two reportable segments namely human health and animal health. The company generates the majority of its revenue from the Human Health segment.

Founded: 2013 Country:
United States
United States
Employees: N/A City: SAN FRANCISCO
Market Cap: 32.8M IPO Year: N/A
Target Price: N/A AVG Volume (30 days): 61.7M
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -1.79 EPS Growth: N/A
52 Week Low/High: $0.05 - $1.22 Next Earning Date: 05-13-2024
Revenue: $9,761,000 Revenue Growth: -18.36%
Revenue Growth (this year): 44.31% Revenue Growth (next year): 86.68%

Share on Social Networks: